Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Ophthalmology
    • LV Prasad Eye...

    LV Prasad Eye Institute, Sheffield Uni organise workshop for finding innovative solutions to treat blindness

    Written by supriya kashyap kashyap Published On 2017-04-21T11:00:20+05:30  |  Updated On 21 April 2017 11:00 AM IST
    LV Prasad Eye Institute, Sheffield Uni organise workshop for finding innovative solutions to treat blindness

    Hyderabad : The University of Sheffield, UK and L V Prasad Eye Institute, India are jointly organising a four day workshop from April 20-23, 2017 in Hyderabad to discuss innovative scientific solutions for treating damaged corneas, a part of the eye essential for sight.


    This workshop on “Application of innovative chemistry and bio materials to treat corneas damaged by trauma, disease and infection” is part of the Newton-Bhabha Researcher Links programme, aimed at bringing together UK researchers with their counterparts in India, to exchange ideas and solve global problems.


    For the second year in a row, the Royal Society of Chemistry, in association with the British Council through Newton Fund, are investing INR 2.5 crores, to deliver nine Newton Researcher Links workshops, to provide Indian and UK researchers with the opportunity to learn from each other and build long-lasting, sustainable research collaborations.


    As many as 10 million people in India suffer from blindness many of these due to problems with the cornea.


    A healthy cornea is transparent, but infection, trauma or inherited disorders can cause damage, leading to partial or total loss of sight. Bacterial and fungal infections can also damage the cornea, leading to corneal ulceration and often loss of the whole eye. Bacterial infection in particular is a growing problem, due to increasing resistance to antibiotics.


    Each of the early career scientists will have the opportunity to present their research, and senior scientists will attend as mentors, to lead discussions and provide guidance.


    “The delegates are mostly early career scientists with expertise in either chemistry or bio materials, from both India and the UK. They were selected from a large and competitive pool of applications. This is an exciting opportunity for young experts, from diverse backgrounds and with new ideas, to come together and focus on the practical clinical problems of corneal blindness. Through the workshop, we hope to establish new collaborations between the UK and India, and nurture a new generation of young scientists able to respond to this urgent clinical need.”


    Mei-kwei Barker, Director, British Council South India said, “The British Council’s global reach and commitment to building strong international relationships enables us to better support Science. Through the Newton Bhabha Fund we will use the UK’s strengths in research and innovation to support greater scientific research capacity in India and build research partnerships between British and India research institutions. Over the years, we have supported 250+ Early Career Researchers and will support another 300 this year. We hope that the skills and knowledge developed through this partnership will make a significant contribution to various fields underpinning science.”


    Dr Vivek Singh (Scientist) L V Prasad Eye Institute said: “Our focus is on ocular regeneration, and ways and means to do so using all available science & technology methods, and devise novel solutions wherever possible. The major goal is to eliminate corneal blindness. This would involve (a) ocular stem cell biology and therapy for the cornea, (b) replacement of cells and tissues using bio compatible materials (artificial cornea), (c) explore 3D printing of tissues and organ parts such as the cornea using cells or even using liquid cornea concept for sealing the corneal stromal defects. Ours is a long term commitment to try and tackle the problem of corneal blindness, affecting millions across the world. ”


    Professor Sheila MacNeil University of Sheffield said: “Working in partnership with colleagues in L V Prasad has been really inspirational. It is a privilege to be able to work with international calibre clinical innovators to tackle clinical problems of vision which can translate into improved therapy for patients suffering from loss of vision due to cornea problems.”

    blindnesscorneaDr Vivek Singhfungal infectionsL V Prasad Eye InstituteMei-kwei BarkerRoyal Society of ChemistryUniversity of Sheffield
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok